CD28 positive, cytomegalovirus specific cytotoxic T lymphocytes as a novel biomarker associated with cytomegalovirus viremia in kidney allorecipients-Reference-Cited by-同舟云学术

CD28 positive, cytomegalovirus specific cytotoxic T lymphocytes as a novel biomarker associated with cytomegalovirus viremia in kidney allorecipients

Published:2016-10 Issue: Volume:83 Page:17-25
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Zieliński Maciej^ORCID,Tarasewicz Agnieszka,Zielińska Hanna,Jankowska Magdalena,Moszkowska Grażyna,Dębska-Ślizień Alicja,Rutkowski Bolesław,Trzonkowski Piotr

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference31 articles.

1. The pathogenesis of human cytomegalovirus;Griffiths;J. Pathol.,2015

2. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation;Kotton;Transplantation,2013

3. CMV: prevention, diagnosis and therapy;Kotton;Am. J. Transplant.,2013

4. Cytomegalovirus risk factors in renal transplantation with modern immunosuppression;Bataille;Transpl. Infect. Dis.,2010

5. Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients;Rowshani;Transplantation,2005

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune-checkpoint expression in antigen-presenting cells (APCs) of cytomegaloviruses infection after transplantation: as a diagnostic biomarker;Archives of Microbiology;2023-07-10

2. T‐lymphocyte subtyping: an early warning and a potential prognostic indicator of active cytomegalovirus infection in patients with sepsis;Immunology & Cell Biology;2022-10-12

3. Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation;Haematologica;2022-10-06

4. Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 Vaccine;Frontiers in Immunology;2022-07-22

5. Comparison of Humoral and Cellular CMV Immunity in Patients Awaiting Kidney Transplantation;Diagnostics;2021-09-16